SCOPUS 정보 검색 플랫폼

Journal of Clinical Lipidology

Volumn 6, Issue 2, 2012, Pages 98-104

The use of lipopheresis in the practice of clinical lipidology

(4) Brown, W Virgil a Brook, Robert b Hemphill, Linda C c Moriarty, Patrick M d

a EMORY UNIVERSITY SCHOOL OF MEDICINE (United States)

b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL (United States)

c MASSACHUSETTS GENERAL HOSPITAL (United States)

d UNIVERSITY OF KANSAS MEDICAL CENTER (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN E4; BRADYKININ; CHOLESTEROL; DEXTRAN SULFATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EZETIMIBE; HEPARIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SERUM AMYLOID A; VERY LOW DENSITY LIPOPROTEIN;

ANAPHYLAXIS; APHERESIS; ARTERIOVENOUS FISTULA; BODY SIZE; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; CORONARY ARTERY DISEASE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE COST; HUMAN; HYPERCHOLESTEROLEMIA; HYPOTENSION; INDWELLING CATHETER; LIPID ANALYSIS; LIPOPHERESIS; MEDICAID; MEDICARE; NEPHROTIC SYNDROME; PATIENT COMPLIANCE; PERIPHERAL VASCULAR DISEASE; PH; PLASMAPHERESIS; PRECIPITATION; PRIORITY JOURNAL; REVIEW; THROMBOCYTOPHERESIS; VEIN BLOOD FLOW;

BLOOD COMPONENT REMOVAL; HUMANS; LIPOPROTEINS, LDL;

EID: 84857919743 PISSN: 19332874 EISSN: 18764789 Source Type: Journal
DOI: 10.1016/j.jacl.2011.12.003 Document Type: Review

Times cited : (6)

References (15)

1
- 0027946431
- The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concentrations and the course of coronary heart disease
- P. Schuff-Werner, H. Gohlke, and U. Bartmann The HELP-LDL-apheresis multicenter study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concentration and the course of coronary heart disease Eur J Clin Invest 24 1994 724 732 (Pubitemid 24358557)
- (1994) European Journal of Clinical Investigation , vol.24 , Issue.11 , pp. 724-732
- Schuff-Werner, P.¹ Gohlke, H.² Bartmann, U.³ Baggio, G.⁴ Corti, M.C.⁵ Dinsenbacher, A.⁶ Eisenhauer, T.⁷ Grutzmacher, P.⁸ Keller, C.⁹ Kettner, U.¹⁰ Kleophas, W.¹¹ Koster, W.¹² Olbricht, C.J.¹³ Richter, W.O.¹⁴ Seidel, D.¹⁵

2
- 0032520169
- Long-term effects of low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system
- DOI 10.1016/S0002-9149(97)00947-8, PII S0002914997009478
- B.R. Gordon, S.F. Kelsey, and P.C. Dau Long-term effects of low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Liposorber Study Group Am J Cardiol 81 1998 407 411 (Pubitemid 28099529)
- (1998) American Journal of Cardiology , vol.81 , Issue.4 , pp. 407-411
- Gordon, B.R.¹ Kelsey, S.F.² Dau, P.C.³ Gotto Jr., A.M.⁴ Graham, K.⁵ Illingworth, D.R.⁶ Isaacsohn, J.⁷ Jones, P.H.⁸ Leitman, S.F.⁹ Saal, S.D.¹⁰ Stein, E.A.¹¹ Stern, T.N.¹² Troendle, A.¹³ Zwiener, R.J.¹⁴

3
- 0032439751
- Safety and effectiveness of long-term LDL-apheresis in patients at high risk
- DOI 10.1097/00041433-199812000-00002
- J. Thiery, and D. Seidel Safety and effectiveness of long-term LDL-apheresis in patients at high risk Curr Opin Lipidol 9 1998 521 526 (Pubitemid 29041445)
- (1998) Current Opinion in Lipidology , vol.9 , Issue.6 , pp. 521-526
- Thiery, J.¹ Seidel, D.²

4
- 0033998553
- LDL-apheresis removes serum amyloid P and A in hypercholesterolemic patients
- DOI 10.1016/S0049-3848(99)00206-6, PII S0049384899002066
- B. Palumbo, L. Cardinali, and H. Sinzinger LDL-apheresis removes serum amyloid P and A in hypercholesterolemic patients Thromb Res 97 2000 491 494 (Pubitemid 30125716)
- (2000) Thrombosis Research , vol.97 , Issue.6 , pp. 491-494
- Palumbo, B.¹ Cardinali, L.² Sinzinger, H.³

5
- 17944363477
- Significantly rapid relief from steroid-resistant nephrotic syndrome by LDL apheresis compared with steroid monotherapy
- DOI 10.1159/000046112
- E. Muso, M. Mune, and Y. Fujii Significantly rapid relief from steroid-resistant nephrotic syndrome by LDL apheresis compared with steroid monotherapy Nephron 89 2001 408 415 (Pubitemid 33135820)
- (2001) Nephron , vol.89 , Issue.4 , pp. 408-415
- Muso, E.¹ Mune, M.² Fujii, Y.³ Imai, E.⁴ Ueda, N.⁵ Hatta, K.⁶ Imada, A.⁷ Takemura, T.⁸ Miki, S.⁹ Kuwahara, T.¹⁰ Takamitsu, Y.¹¹ Tsubakihara, Y.¹²

6
- 0142103707
- LDL-apheresis up-regulates VEGF and IGF-I in patients with ischemic limb [see comment]
- DOI 10.1002/jca.10055
- S. Kobayashi, H. Moriya, and K. Negishi LDL-apheresis up-regulates VEGF and IGF-I in patients with ischemic limb [see comment] J Clin Apheresis 8 2003 115 119 (Pubitemid 37280781)
- (2003) Journal of Clinical Apheresis , vol.18 , Issue.3 , pp. 115-119
- Kobayashi, S.¹ Moriya, H.² Negishi, K.³ Maesato, K.⁴ Ohtake, T.⁵

7
- 20344385998
- The double jeopardy of HDL
- DOI 10.1080/07853890510007322
- M. Navab, G.M. Ananthramaiah, and S.T. Reddy The double jeopardy of HDL Ann Med 37 2005 173 178 (Pubitemid 40780434)
- (2005) Annals of Medicine , vol.37 , Issue.3 , pp. 173-178
- Navab, M.¹ Ananthramaiah, G.M.² Reddy, S.T.³ Van Lenten, B.J.⁴ Ansell, B.J.⁵ Hama, S.⁶ Hough, G.⁷ Bachini, E.⁸ Grijalva, V.R.⁹ Wagner, A.C.¹⁰ Shaposhnik, Z.¹¹ Fogelman, A.M.¹²

8
- 33644980996
- LDL-apheresis improves peripheral arterial occlusive disease with an implication for anti-inflammatory effects
- S. Kobayashi, H. Moriya, and K. Maesato LDL-apheresis improves peripheral arterial occlusive disease with an implication for anti-inflammatory effects J Clin Apheresis 20 2005 239 243
- (2005) J Clin Apheresis , vol.20 , pp. 239-243
- Kobayashi, S.¹ Moriya, H.² Maesato, K.³

9
- 35348835530
- Effect of low-density lipoprotein apheresis on inflammatory and noninflammatory high-density lipoprotein cholesterol
- DOI 10.1016/j.amjcard.2007.06.033, PII S0002914907014609
- I.O. Opole, J.M. Belmont, A. Kumar, and P.M. Moriarty Effect of low-density lipoprotein apheresis on inflammatory and noninflammatory high-density lipoprotein cholesterol Am J Cardiol 100 2007 1416 1418 (Pubitemid 47576021)
- (2007) American Journal of Cardiology , vol.100 , Issue.9 , pp. 1416-1418
- Opole, I.O.¹ Belmont, J.M.² Kumar, A.³ Moriarty, P.M.⁴

10
- 54549104832
- Long-term safety and efficacy of low-density lipoprotein apheresis in childhood for homozygous familial hypercholesterolemia
- L.C. Hudgins, B. Kleinman, A. Scheuer, S. White, and B.R. Gordon Long-term safety and efficacy of low-density lipoprotein apheresis in childhood for homozygous familial hypercholesterolemia Am J Cardiol 102 2008 1199 1204
- (2008) Am J Cardiol , vol.102 , pp. 1199-1204
- Hudgins, L.C.¹ Kleinman, B.² Scheuer, A.³ White, S.⁴ Gordon, B.R.⁵

11
- 61549101898
- Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events
- B.R. Jaeger, Y. Richter, and D. Nagel Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events Nat Clin Pract Cardiovasc Med 6 2009 229 239
- (2009) Nat Clin Pract Cardiovasc Med , vol.6 , pp. 229-239
- Jaeger, B.R.¹ Richter, Y.² Nagel, D.³

12
- 77952325552
- Effect of low-density lipoprotein apheresis on plasma levels of apolipoprotein E4
- P.M. Moriarty, J.P. Luyendyk, C.A. Gibson, and J.M. Backes Effect of low-density lipoprotein apheresis on plasma levels of apolipoprotein E4 Am J Cardiol 105 2010 1585 1587
- (2010) Am J Cardiol , vol.105 , pp. 1585-1587
- Moriarty, P.M.¹ Luyendyk, J.P.² Gibson, C.A.³ Backes, J.M.⁴

13
- 78649888517
- Lipoprotein(a) as a cardiovascular risk factor: Current status: EAS Consensus Panel
- B.G. Nordestgarrd, and M.J. Chapman Lipoprotein(a) as a cardiovascular risk factor: current status: EAS Consensus Panel Eur Heart J 31 2010 2844 2853
- (2010) Eur Heart J , vol.31 , pp. 2844-2853
- Nordestgarrd, B.G.¹ Chapman, M.J.²

14
- 79959747118
- Atheroprotective reverse cholesterol transport pathway is defective in familial hypercholesterolemia
- N. Ballanger, A. Orsoni, and Z. Julia Atheroprotective reverse cholesterol transport pathway is defective in familial hypercholesterolemia Aterioscler Thromb Vasc Biol 31 2011 1675 1681
- (2011) Aterioscler Thromb Vasc Biol , vol.31 , pp. 1675-1681
- Ballanger, N.¹ Orsoni, A.² Julia, Z.³

15
- 82555171556
- What homozygous familial hypercholesterolemia produces and the will to withstand its complications
- M. Zamirian What homozygous familial hypercholesterolemia produces and the will to withstand its complications Am J Cardiol 108 2011 1840 1841
- (2011) Am J Cardiol , vol.108 , pp. 1840-1841
- Zamirian, M.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.